Risk Stratification in Unstable Angina Prospective Validation of the Braunwald Classification JAMA, January 11, 1995-Vol.273,No. 2.

Slides:



Advertisements
Similar presentations
ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.
Advertisements

Ischaemic Heart Disease- Implications of Gender Dr Kaye Birks School of Rural Health Monash University Australia Gender Competency Training for Medical.
Sumeet Subherwal, Richard G. Bach, Anita Y. Chen, Brian F. Gage, Sunil V. Rao, Tracy Y. Wang, W. Brian Gibler, E. Magnus Ohman, Matthew T. Roe, Eric D.
V.: 9/7/2007 AC Submit1 Statistical Review of the Observational Studies of Aprotinin Safety Part I: Methods, Mangano and Karkouti Studies CRDAC and DSaRM.
Presenters for Journal Club: James Cooper Eugenie Shieh Aaron Schueneman Tim Niessen.
Comparison of the New Mayo Clinic Risk Scores and Clinical SYNTAX Score in Predicting Adverse Cardiovascular Outcomes following Percutaneous Coronary Intervention.
Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
Relationship of Time to Treatment and Door-to-Balloon Time to Mortality in Patients with Acute Myocardial Infarction Treated with Primary Angioplasty Christopher.
TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.
The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) The LIPID Study Group N Engl J Med 1998;339:
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Comparison of AngioJET Rheolytic Thrombectomy Before Direct Infarct Artery STENTing in Patients with Acute Myocardial Infarction: the JETSTENT trial David.
Ischemic Heart Disease Group of diseases Most common cause of death in developed countries Terminology: 1.Angina pectoris 2.Myocardial infarction 3.Sudden.
COMMIT/CCS-2 (ClOpidogrel & Metoprolol in Myocardial Infarction Trial)
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
ACUTE CORONARY SYNDORME EARLY RISK STRATIFICATION Sarah Jamison March 2003.
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
Clinical Trial Results. org Pexelizumab for Acute ST-Elevation Myocardial Infarction in Patients Undergoing Primary Percutaneous Coronary Intervention.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
University Medical Center Groningen Thrombus aspiration during primary PCI FZ Thrombus Aspiration during Percutaneous coronary intervention in Acute.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Chest Pain & Unstable Angina Eugene Yevstratov MD Based on UCLA protocol of the management of Chest Pain & Unstable Angina.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
Blood Pressure Lability During Cardiac Surgery Is Associated With Adverse Outcomes Solomon Aronson, Edwin G. Avery, Cornelius Dyke, Joseph Varon, Jerrold.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Author: Moldovan Carmen Co-authors: Opincariu Diana Balan Daniel University of Medicine and Pharmacy Tg. Mures Cardiology Clinic, Mures Emergency Clinical.
Impact of Drug-Eluting Stents on Revascularization Choices in Patients with Acute Coronary Syndromes and Multivessel Coronary Disease: Results from the.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. MYOCARDIAL INFARCTION Prof.
Anything that you want to know about troponins but never ask
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
Acute Heart Failure in Apical Ballooning Syndrome (Takotsubo/Stress Cardiomyopathy) Clinical Correlates and Mayo Clinic Risk Score Malini Madhavan, MBBS;
CONFIDENTIAL SLIDE SET FOR THE CHAIR OF THE ACC08 Late Breaker; embargoed until 1 April 2008 Long-term Cardiac Arrhythmias recorded by Insertable Loop.
Collaborative Atorvastatin Diabetes Study CARDS Dr Sachin Kadoo.
Community Outreach to Reduce Disparities in Cardiovascular & Diabetes Morbidity & Mortality in the South Bronx Michael Alderman, MD Michelle Johnson, MD,
Endeavor Safety: Pooled Analysis of Early and Late Safety of a Zotarolimus-Eluting Stent Laura Mauri, MD, MSc Brigham and Women’s Hospital Harvard Clinical.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
Clinical Trial Results. org Characteristics, Management, and Outcomes of 5,557 Patients Age ≥90 Years With Acute Coronary Syndromes: Results From the CRUSADE.
Heart rate in heart failure: Heart rate in heart failure: risk marker or risk factor? A subanalysis of the SHIFT trial on behalf of the Investigators M.
Antiplatelet Interventions in Acute Coronary Syndromes.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
Effect of Intravascular Ultrasound- Guided vs. Angiography-Guided Everolimus-Eluting Stent Implantation: the IVUS-XPL Randomized Clinical Trial Myeong-Ki.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Relationship Between Operator Volume and Adverse.
Duration Safety and Efficacy of Bivalirudin in patients undergoing PCI: The impact of duration of infusion in ACUITY trial Dr. David Cox Lehigh Valley.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
○ South Asians (SAs) have high rates of CHD which are not entirely explained by traditional CVD risk factors. ○ The association of a family history of.
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Indication Contraindication Preparation
Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: N-terminal pro brain natriuretic peptide on admission.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
Risk Stratification of Chest Pain: Best Practices
Chest Pain & Unstable Angina Eugene Yevstratov MD
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
Journal of Nuclear Cardiology | Official Journal of the American Society of Nuclear Cardiology Prediction of 14-year cardiovascular outcomes by dobutamine.
Copyright © 2009 American Medical Association. All rights reserved.
European Heart Association Journal 2007 April
Giuseppe Biondi Zoccai, MD
TIMI IIIA Protocol Design 391 Patients with Unstable Angina / NQWMI
Impact of Platelet Reactivity Following Clopidogrel Administration
Division of Cardiovascular Diseases No relevant author disclosures
Potassium levels and risk of in-hospital arrhythmias and mortality in patients admitted with suspected acute coronary syndrome  Jonas Faxén, Hong Xu,
Presentation transcript:

Risk Stratification in Unstable Angina Prospective Validation of the Braunwald Classification JAMA, January 11, 1995-Vol.273,No. 2

Study summary : validation cohort of 393 consecutive patients, admitted for unstable angina, and followed prospectively for in-hospital complications including MI and death main outcome measures accounted for major cardiac complications including death, myocardial infarction, CHF, cardiogenic shock, and severe ventricular arrhythmias Risk Stratification in Unstable Angina JAMA, January 11, 1995-Vol.273,No. 2 Four clinical factors which are used in the Braunwald classification predicted major complications: (1) MI within less than 14 days (2) need for IV nitroglycerin (3) lack of  blocker/CCB prior to admission (4) baseline ST depression *diabetes and age were also significant predictors, as determined in the analysis*

Classification of angina as proposed by Braunwald A. In the presence of an B.No exacerbating C. Within Extracardiac condition Extracardiac 2 weeks that intensifies Condition after M.I. Severity myocardial infarction I. New onset of severe or accelerated angina; no rest pain II. Angina at rest within past month, but not within preceding 48 hours III. Angina at rest within last 48 hours IA IIA IIIA IBIC IIBIIC IIIBIIIC JAMA, January 11, 1995-Vol.273,No. 2

Comparison between all complicated and uncomplicated patients with unstable angina Complicated Uncomplicated Number (%) Number (%) CHARACTERISTIC (N=77) (N=316) P rest pain 62 (81) 248 (79) 0.77 progressive angina 15 (20) 65 (21) 0.82 baseline ST depression 22 (29) 49 (16).007 positive family history 31 (40) 102 (32) 0.18 hypertension 49 (64) 188 (60) 0.51 elevated cholesterol 26 (34) 120 (38) 0.49 diabetes* 42 (55) 108 (34).001 previous MI 33 (43) 98 (31) 0.05 post M I (<14 days) 11 (14) 11 (4).001 requiring IV NTG 33 (43) 82 (26).003  blocker/rate CCB 8 (10) 82 (26).004 history of smoking 42 (55) 121 (38).009 Aspirin use 68 (88) 288 (91) 0.45 age* 67 (15) 61 (17).004 JAMA, January 11, 1995-Vol.273,No. 2

Comparison between complicated (MI/ death) and Uncomplicated patients with UAP Complicated Uncomplicated Number (%) Number (%) CHARACTERISTIC (N=30) (N=363) P rest pain 25 (83) 286 (79) 0.57 baseline ST depression 12 (40) 59 (16).001 positive family history 14 (47) 119 (33) 0.12 hypertension 21 (40) 216 (60) 0.26 elevated cholesterol 13 (43) 133 (37) 0.48 diabetes* 18 (60) 132 (36) 0.01 previous MI 14 (47) 117 (32) 0.11 post M I (<14 days) 6 (20) 16 (4).001 requiring IV NTG 14 (47) 101 (28) 0.03  blocker/rate CCB 2 (7) 88 (24) 0.03 history of smoking 16 (53) 147 (41) 0.18 exacerbating condition 5 (17) 34 (9) 0.20 age* 68 (16) 62 (17) 0.06 JAMA, January 11, 1995-Vol.273,No. 2

Predictors of all major cardiac complications using Braunwald Factors’ alone 95% Odds Confidence VariableRatio Interval P Post M I (< 14 days) Requiring IV NTG on admission No beta-blocker or rate lowering CCB Baseline ST depression Constant JAMA, January 11, 1995-Vol.273,No. 2

Predictors of all major cardiac complications using Braunwald criteria, diabetes and age 95% Odds Confidence VariableRatio Interval P Post M I (< 14 days) Requiring IV NTG on admission No beta-blocker or rate lowering CCB Baseline ST depression Diabetes Mellitus Incremental decade of age Constant JAMA, January 11, 1995-Vol.273,No. 2

Predictors of myocardial infarction and death 95% Odds Confidence VariableRatio Interval P Post M I (< 14 days) No beta-blocker or rate lowering CCB Baseline ST depression Diabetes Mellitus Constant JAMA, January 11, 1995-Vol.273,No. 2